New FDA Guidance on the Use of Multiple Endpoints in Clinical Trials
The U.S. Food and Drug Administration (FDA) issued a new final guidance, Multiple Endpoints in Clinical Trials Guidance for Industry. As the number of endpoints...
Read The Article